Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients

NCT05961761 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Soft Tissue Sarcoma Adult
Angiosarcoma
Undifferentiated Pleomorphic Sarcoma

Interventions

DRUG: Propranolol
DRUG: Pembrolizumab

Sponsor

Niels Junker

Collaborators

[object Object]
[object Object]
[object Object]